Prenatal ultrasounds are a vital part of monitoring a baby’s development, but studies show they miss up to half of fetal abnormalities. A new AI-powered tool cleared by the U.S. FDA could help doctors spot problems earlier and more reliably.
Real-Time Assistance During Scans
The software, developed by American start-up BioticsAI, works alongside existing ultrasound machines. It analyzes images as they are captured, checking for quality, suggesting adjustments for a clearer view, and ensuring all parts of the fetus are visible.
Using global data patterns, the AI can detect potential issues like heart or limb defects, flagging them for the doctor immediately. After the scan, it produces a comprehensive report, helping clinicians save time—around eight minutes per patient—on documentation.
Addressing Gaps in Detection
Current prenatal screening can miss many congenital anomalies. According to the European Commission, roughly 24 out of every 10,000 births involve major congenital anomalies. Cochrane’s review of over seven million pregnancies found that a single early scan detects only 38% of birth defects, while a mid-pregnancy scan finds 51%. Performing both scans increases detection to 84%, but gaps remain.
Global AI Solutions on the Rise
Europe is also embracing AI in prenatal care. French companies Diagnoly and Sonio Detect have received approval for software that automatically identifies fetal structures and heart conditions. With tools like these, doctors are better equipped to detect issues early, giving families more information and peace of mind.
